Holen Sie sich die Stockscreener-App
0.9741
3.55%
-0.0359
Handel nachbörslich:
.98
0.0059
+0.61%
Finanzdaten der Pds Biotechnology Corporation-Aktie (PDSB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
23.71%
9.1058
|
7.3606 | 10.18 | 8.6843 | 10.10 |
| Operating Income/Loss |
23.71%
-9.1058
|
-7.3606 | -10.18 | -8.6843 | -10.10 |
| Income/Loss From Continuing Operations Before Tax |
21.46%
-9.6588
|
-7.9524 | -10.73 | -9.1971 | -10.60 |
| Income Tax Expense/Benefit, Current |
-
|
- | - | - | - |
| Income Tax Expense/Benefit |
-1.1698
|
- | - | -0.8692 | - |
| Income/Loss From Continuing Operations After Tax |
6.75%
-8.489
|
-7.9524 | -10.73 | -8.3279 | -10.60 |
|
Net Income/Loss
|
6.75%
-8.489
|
-7.9524 | -10.73 | -8.3279 | -10.60 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
11,652%
40.52
|
0.3448 | 36.81 | 36.69 | 34.82 |
| Diluted Average Shares |
11,652%
40.52
|
0.3448 | 36.81 | 36.69 | 34.82 |
| Basic Earnings Per Share |
0.00%
-0.21
|
-0.21 | -0.29 | -0.23 | -0.30 |
| Diluted Earnings Per Share |
0.00%
-0.21
|
-0.21 | -0.29 | -0.23 | -0.30 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.08%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):